from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1714/-

LFCtreatmentdescriptionclass of inhibitor

0.046

Amikacinug/mL Amikacintranslation

-0.827

Cap5-10ug/mL Capreomycintranslation

0.073

Rox10-50 ug/mL Roxithromycintranslation

-0.646

SM2-5 ug/mL Streptomycintranslation

-1.312

Tet5-10 ug/mL Tetracyclinetranslation

1.113

Rif0.2-5ug/mL Rifampicintranscription

0.785

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.117

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.651

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.071

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.445

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.136

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.456

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.386

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.458

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.368

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.461

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.222

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.793

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.881

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.072

KCN5-20 ug/mL Potassium cyaniderespiration

1.370

NaN30.2-2 mM Sodium aziderespiration

-0.458

Nigericin50 uM Nigericinrespiration

0.455

TRC10-150 ug/mL Triclosanrespiration

0.020

TRZ10-25 ug/mL Thioridazinerespiration

-0.049

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.038

menadione6-10 ug/mL Menadionerespiration

0.035

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.055

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.157

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.554

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.813

NRP_1Non-replicating persistence stage 1dosRassociated

-1.072

Amp0.2mg/mL AmpicillincellWall

-0.150

Cephalexin20-100 ug/mL CephalexincellWall

-0.264

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.648

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.688

EMB10-20 ug/mL EthambutolcellWall

-0.953

Eta12-40 ug/mL EthionamidecellWall

-0.779

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.333

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.381

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.186

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.886

BZA0.12 mg/mL BenzamidearomaticAmides

0.553

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.115

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.248

H2O24 mM hydrogen peroxideDNAdamaging

0.884

Levo10 ug/mL LevofloxacinDNAdamaging

0.011

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.268

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.646

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.314

UVUV-irradiationDNAdamaging

0.722

ARP41-4 ug/mL Antitubercular compound ARP4?

0.057

Antimycin12.5-50 ug/mL Antimycin A?

0.273

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.573

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.254

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.750

PA8240.2-2 ug/mL PA-824?

-0.367

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.148

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.361

Verapamil50 uM Verapamil?

1.007

mercaptoethanol2 mM 2-Mercaptoethanol?

0.192

methoxatin10-20 ug/mL Methoxatin?